Kirsten-rat-sarcoma viral oncogene homolog (KRAS) is the most common mutation driving factor, accounting for 15–30% of all human malignant tumors, and KRAS mutations are particularly common in pancreatic ductal adenocarcinoma, colorectal cancer, and NSCLC [7]. This evidence concerns the gene KRAS and cancer.